INMD Stock Risk & Deep Value Analysis

Inmode Ltd

DVR Score

8.7

out of 10

Hidden Gem

What You Need to Know About INMD Stock

We analyzed Inmode Ltd using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran INMD through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Moderate. Here's what we found.

Updated Mar 16, 2026Run Fresh Analysis →

How Risky Is INMD Stock?

Overall Risk

Moderate

Financial Risk

Low

Market Risk

Medium

Competitive Risk

Medium

Execution Risk

Medium

Regulatory Risk

Medium

What Are the Red Flags for INMD?

  • Slower-than-expected recovery in consumer discretionary spending for aesthetics

  • New, highly competitive technology emerging from rivals

  • Negative regulatory changes impacting medical device sales or approvals

  • Increased price pressure on devices or consumables

Unlock INMD Red Flags & Risk Warnings

Create a free account to see the full analysis

Is INMD Stock Undervalued?

InMode retains significant 10x potential within 3-5 years, underpinned by its market leadership in minimally invasive aesthetic devices. The company's proprietary RF technology (e.g., Morpheus8) continues to drive brand recognition and a sticky business model with recurring consumable revenue. Financial health remains exceptionally strong (debt-free, cash-rich, consistently profitable). While macro headwinds have slowed growth over the past year, the core strategic vision for market expansion and innovation is intact. Leadership is proven, and a low current valuation, combined with strong fundamentals and ongoing product development, creates a compelling risk-reward profile for substantial re-rating as market conditions normalize and growth re-accelerates. No significant red flags indicate a 'dud'.

Unlock the full AI analysis for INMD

Get the complete DVR score, risk analysis, and more

Does INMD Have a Competitive Moat?

Sign in to unlock

Moat Rating

🛡️ Narrow

Moat Trend

Stable

Moat Sources

3 Identified

Intangible Assets/IPBrand PowerSwitching Costs

InMode's moat is largely protected by its proprietary radiofrequency (RF) technology and a robust patent portfolio. The strong brand recognition of products like Morpheus8 creates significant customer loyalty and a network effect among clinicians. Switching costs arise from the training required to operate InMode platforms and the continued purchase of proprietary consumables. However, the medical aesthetics market is dynamic, requiring continuous innovation to maintain this edge.

Moat Erosion Risks

  • Emergence of a genuinely disruptive, non-RF based aesthetic technology
  • Patent expirations or successful challenges to IP
  • Aggressive pricing strategies by competitors leading to margin erosion

INMD Competitive Moat Analysis

Sign up to see competitive advantages

What Could Drive INMD Stock Higher?

Near-Term (0-6 months)

  • Q1 2026 Earnings (Estimated early-May 2026)
  • Launch of new handpieces or software upgrades for existing platforms
  • Positive commentary on recovery of elective procedure demand

Medium-Term (6-18 months)

  • Expansion into new international markets (e.g., Asia Pacific, Latin America)
  • Major regulatory approvals for new platforms or indications
  • Strategic partnerships to expand clinic adoption or training programs

Long-Term (18+ months)

  • Further penetration into the broader medical aesthetics market, potentially through M&A
  • Disruption of traditional surgical procedures with less invasive alternatives
  • Establishment of InMode as the dominant player in RF-based aesthetics

Catalysts & Growth Drivers

Upgrade to Premium to see catalysts

What's the Bull Case for INMD?

  • Acceleration in year-over-year and sequential revenue growth rates

  • Positive commentary and strong guidance from management regarding market recovery

  • Continued high adoption rates of new product launches and handpieces

Bull Case Analysis

See what could go right with Premium

Compare INMD to Similar Stocks

See how Inmode Ltd stacks up against related companies in our head-to-head analysis.

📊 Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.

Important Disclaimer – Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for INMD (Inmode Ltd) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.

More Resources to Boost Your Portfolio

Explore our other guides and tools to maximize your investment returns

5-Minute Guide Thumbnail

6 Simple Steps Spotting Undervalued Stocks

Learn More
Dividend Stocks Thumbnail

Earn $500/Month with Dividend Stocks

Learn More
Swing Trading Guide Thumbnail

3 Swing Trading Strategies for Predictable Gains

Learn More
Navigated to INMD Stock Risk & Deep Value Analysis